Politics

German Parliament Greenlights Plan for Cannabis Prescriptions

Published on January 19, 2017 · Last updated July 28, 2020
Berlin Reichstag Dome at Sunset. Modern monument with spiral walkways to the top of the Reichstag, Germany's parliament building in the heart of Berlin, Central Berlin, Germany.

German lawmakers have approved legislation that would allow some patients to get cannabis as a prescription-only medication.

The German Parliament’s lower house passed the bill unanimously on Thursday, clearing the way for the law to take effect in March.

Health Minister Hermann Groehe has stressed the move does not mean marijuana will be legal for non-medical purposes.

“Seriously ill people must be cared for in the best way possible,” Groehe said, which includes allowing the public health system to fund cannabis prescriptions for patients “if they cannot effectively be helped any other way.”

The country’s progress on medical cannabis is noteworthy, as up until early 2016, the country’s health ministry had insisted there was no need for such a program. Instead the country required that German patients obtain special authorization from the government. The restrictions meant that few of the thousands of patients seeking cannabis for treatment were able to secure it.

High costs have also frustrated patients seeking medical cannabis. Under the forthcoming program, expenses for cannabis flower and extracts will be covered by health insurance for patients who have no other treatment options.

Under the bill approved by lawmakers this week, prescriptions will be filled with imported cannabis until a domestic cultivation program is up and running. Cannabis is currently imported from the Netherlands, although the Dutch have said they cannot meet the skyrocketing demand in Europe.

Germany is not the only European country considering changes to its cannabis policies. Several other European countries, such as Croatia, Italy, and the Czech Republic, are acting to get legal cannabis markets off the ground in hopes of improving patients’ quality of life while enabling scientific research. And late last year Irish lawmakers approved a landmark medical cannabis program in that country.

The Associated Press contributed to this report.

Story updated at 12:06 p.m.

Shop highly rated stores near you

Showing you stores near
See all stores
Leafly Staff
Leafly Staff
Leafly is the world’s largest cannabis information resource, empowering people in legal cannabis markets to learn about the right products for their lifestyle and wellness needs. Our team of cannabis professionals collectively share years of experience in all corners of the market, from growing and retail, to science and medicine, to data and technology.
View Leafly Staff's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




The material provided on Leafly is intended for educational and informational purposes only. Leafly is not engaged in rendering medical service or advice and the information provided is not a substitute for a professional medical opinion. If you have a medical problem, please contact a qualified health professional.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.